NASDAQ · Shell Companies · USD

Leapfrog Acquisition Corporation (LFAC) Stock Analysis

Leapfrog Acquisition Corporation (LFAC) is a Shell Companies stock listed on NASDAQ and quoted in US Dollar.

LFAC

$10.07

$0.00 (0.00%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare LFAC with… →

LFAC Key Statistics

As of Sep 4, 2026

Trading

Open: $10.07
Previous Close: $10.07
52-Week Range: 9.54–10.07

Valuation

Market Cap: $197.77M

Financials (FY)

Profit margin: 0.00%
Shares Outstanding: 14.85M

Dividend and dates

Avg Volume: 23.38K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

LFAC Valuation vs Shell Companies Median

Median of 587 stocks

Metric	LFAC	Shell Companies median	vs median
Profit margin	0.00%	0.00%	0.0 pts above

Medians across 587 Shell Companies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

Leapfrog Acquisition Corporation (LFAC) is capitalised at $197.77M on the latest close. The company sits in the Financial Services sector, in the Shell Companies industry.

The 52-week range on file runs from $9.54 to $10.07. LFAC last closed at $10.07 on September 4, 2026. The close was unchanged from the previous session. The latest close sits 5.61% above that 52-week low.

Financial Health

Profit margin runs at 0%.

Valuation Assessment

The stored price history starts on January 26, 2026, and the total return since then is +1.72%.

Growth & Income

No dividend is on file for LFAC.

So far in 2026 the price is +1.72%.

Peer Comparison

Leapfrog Acquisition Corporation (LFAC) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Leapfrog Acquisition Corporation	LFAC	$197.77M	—
Churchill Capital Corp XI	CCXI	$746.38M	—
Churchill Capital Corp X	CCCX	$711.00M	—
Drugs Made In America Acquisition II Corp.	DMII	$647.83M	35.1

The Shell Companies industry average P/E ratio is 45.2x. Leapfrog Acquisition Corporation has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Shell Companies Stocks

CCXI

Churchill Capital Corp XI

$746.38M

CCCX

Churchill Capital Corp X

$711.00M

DMII

Drugs Made In America Acquisition II Corp.

$647.83M

BCSS

Bain Capital GSS Investment Corp.

$602.40M

EVAC

EQV Ventures Acquisition Corp. II

$602.01M

CXII

Churchill Capital Corp XII

$594.94M

View all Shell Companies stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.08T

JPM

JPMorgan Chase & Co.

$953.33B

Visa Inc.

$700.27B

Mastercard Incorporated

$507.39B

BAC

Bank of America Corporation

$438.31B

View all Financial Services stocks →

About Leapfrog Acquisition Corporation

Leapfrog Acquisition Corporation does not have significant operations. The company focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses. It intends to identify and acquire a business focusing on energy or infrastructure on markets outside the United States. Leapfrog Acquisition Corporation was incorporated in 2025 and is based in Summit, New Jersey.

Visit website →